Regeneron, Sanofi shut down part of arthritis drug study after trial shows benefit for only sickest coronavirus patients

The drug, Kevzara, inhibits a pathway thought to contribute to the lung inflammation in patients with the most severe forms of Covid-19.

from US Top News and Analysis https://ift.tt/2Y8u7Lt